Ionsys
fentanyl
Treatment for PainALZA Corporation Receives Approvable Letter Regarding IONSYS, an Iontophoretic, Fentanyl-containing, Transdermal Analgesic
MOUNTAIN VIEW, Calif., July 27, 2004 -- ALZA Corporation today announced it has received an approvable letter from the U.S. Food and Drug Administration (FDA) regarding a New Drug Application (NDA) for IONSYS.
ALZA submitted a NDA for IONSYS in September 2003. It is working with the FDA to address the agency's letter as quickly as possible.
ALZA Corporation, a member of the Johnson & Johnson family of companies, is a leading developer of drug delivery-based pharmaceutical products.
for further information, please visit www.alza.com
Related Articles:
ALZA Corporation Resubmits U.S. New Drug Application for IONSYS (Fentanyl HCl Patient-Activated Transdermal System) - November 28, 2005
New Drug Applications Archive
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec






